Cold & Cough Remedies - Lithuania

In Lithuania, the revenue in the Cold & Cough Remedies market market in 2024 amounts to US$63.43m.
It is projected to experience an annual growth rate of 8.31% (CAGR 2024-2029).
When compared globally, the United States generates the highest revenue in this market, reaching US$11.19bn in 2024.
In terms of per person revenues, in Lithuania generates US$23.56 in 2024.
Lithuania's growing demand for natural and herbal cold & cough remedies reflects its preference for traditional remedies over pharmaceutical options.

Definition:
The Cold and Cough market comprises over-the-counter natural and synthetic agents to relieve cough, expectorants and sore throat remedies, cold remedies and preparations against flu-like infections. Cough and cold medication includes medicines in the form of pills, syrups, lozenges, sprays, ointments and granulate for external and internal application. Not included are prescription medicines, preparations that are against the state law or are no explicit cold or cough drugs (e.g. painkillers). Among the top-selling medicines for cold and cough are nose sprays, Mucosolvan syrup, Grippostad C, Sinupret forte, Gelomyrtol, Dolo-Dobendan, Aspirin Complex, Bepanthen nose and eye cream, ACC Akut, Neo-Angin, Vick Vaporup, Isla Moos. It includes both products which are exclusively sold in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Additional Information:
The Cold and Cough market comprises revenues, average revenue per capita. Sales channels show online and offline revenue. Revenues include VAT. The market only displays B2C revenues, hence B2B and B2G revenues are not included.
For more information on the data displayed, use the info button next to the boxes.

Natural and synthetic agents
In the form of pills, syrups, creams, lozenges, sprays and granulate
Expectorants and remedies to relieve cough

Prescription medicines
Homeopathic remedies
Painkillers
Candy

The Cold & Cough Remedies market in Lithuania has been experiencing steady growth in recent years.

Customer preferences: Lithuanian consumers have shown a growing preference for over-the-counter cold and cough remedies. This can be attributed to several factors, including the convenience of purchasing these products without a prescription and the increasing awareness of self-care and preventive healthcare. In addition, the busy lifestyles of consumers in Lithuania have led to a higher demand for quick and effective remedies to alleviate cold and cough symptoms.

Trends in the market: One of the key trends in the Cold & Cough Remedies market in Lithuania is the increasing demand for natural and herbal remedies. Consumers are becoming more conscious of the ingredients used in these products and are opting for options that are perceived to be more natural and less likely to cause side effects. This trend is in line with the global shift towards natural and holistic healthcare solutions. Another trend in the market is the rising popularity of combination products that offer relief for multiple cold and cough symptoms. These products are attractive to consumers as they provide a convenient and cost-effective solution to address different symptoms with a single product. This trend is driven by the need for convenience and efficiency in managing cold and cough symptoms.

Local special circumstances: The Cold & Cough Remedies market in Lithuania is influenced by the country's healthcare system and regulatory environment. The availability of over-the-counter remedies without a prescription has contributed to the growth of the market, as consumers can easily access these products. Additionally, the increasing emphasis on self-care and preventive healthcare in Lithuania has created a favorable environment for the growth of the market.

Underlying macroeconomic factors: The growth of the Cold & Cough Remedies market in Lithuania can also be attributed to favorable macroeconomic factors. The country's stable economic growth and rising disposable incomes have increased consumer spending power, allowing them to afford these products. Additionally, the aging population in Lithuania has led to a higher demand for cold and cough remedies, as older individuals are more susceptible to respiratory illnesses.In conclusion, the Cold & Cough Remedies market in Lithuania is experiencing steady growth due to factors such as customer preferences for over-the-counter remedies, the increasing demand for natural and herbal products, and the availability of combination products. The country's healthcare system, emphasis on self-care, and favorable macroeconomic factors also contribute to the growth of the market.

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

The global pharmaceutical industry has experienced significant growth during the past two decades, with revenues totaling around 1.6 trillion U.S. dollars in 2023. With growth like that, the industry's size is now comparable to the gross domestic products (GDPs) of countries like Spain, Mexico, or Australia.